Issue 11: Pleiotropy & molecular multitasking: What’s Pharma’s problem? With David Hoffmann - Part II

Dr. Spelman covers new research on Sambucus ebulus as a topical treatment for eczema, examines Big Pharma’s reaction to pleiotropy, and continues his discussion with David Hoffmann.